Small web banners
Compact formats for partner websites, newsletters and email campaigns.
Spread the word
To help raise awareness and contribute to the success of EBROW + RTI 2027, we kindly invite you to share the latest conference updates using the EBROW + RTI 2027 promotional toolkit below.
The toolkit includes a range of helpful assets, including official banners, presentation templates, and other promotional resources.
We encourage you to download and use these materials across your own channels – including your website, social media, professional networks, meetings, and presentations – to reach a wider audience and help spread the word about this unique joint meeting.
Help us make EBROW + RTI 2027 a successful and memorable meeting. Thank you for your support!
Publish the latest updates about EBROW RTI 2027
Include EBROW RTI 2027 in your newsletters
Like and repost EBROW RTI 2027 social media posts
Inform your colleagues, friends or members directly
For many years, RTI International Forum and the EBROW (European Bronchiectasis Workshop) have provided separate platforms for specialists in bronchiectasis and respiratory tract infections.
As bronchiectasis and respiratory tract infections are increasingly interconnected, with shared challenges and opportunities across research, diagnosis and treatment, it feels like a natural evolution to bring EBROW and RTI Forum together.
So, this time around in 2027, these two established meetings will unite for the first time,
to create a stronger platform for shared learning, debate and collaboration.
EBROW & RTI 2027 in London, England, brings together expertise from across bronchiectasis and respiratory tract infections, giving you the opportunity to explore both fields in one comprehensive multidisciplinary meeting.
Join specialists from across the international respiratory community to:
By bringing these communities together, EBROW & RTI 2027 offers a broader view of the challenges facing respiratory medicine - and a valuable opportunity to learn from each other.
The Conference Programme has been designed to fulfil the latest educational needs of professionals operating in the following areas of specialisation:
Ready-to-use banners, cover artwork and vertical social formats. Download a single asset or get the complete pack.
Download all assets (.zip) ↓Compact formats for partner websites, newsletters and email campaigns.
High-impact horizontal formats for headers, hero areas and campaign pages.
Portrait artwork for promotional documents, announcements and event pages.
A vertical format designed for stories and mobile-first social media.
Follow us online:
Join the online conversation on X (Twitter), Bluesky and LinkedIn using our official event hashtag #EBROWRTI27
Engage with our online community in the following ways:
Coming soon
Michal Shteinberg is heading the bronchiectasis and adult CF service in the Pulmonology institute and CF center, Carmel medical center, Haifa, Israel. She is a Clinical Assistant Professor in the Faculty of medicine at the Technion, Israel Institute of Technology. Her main research interests are bronchiectasis and its overlap with other airway diseases, and adult CF.
Head of the Pulmonology Service at Hospital Clínic de Barcelona and accredited researcher in the IDIBAPS group Inflammation and Repair in Respiratory Diseases. His work focuses on airway infection, inflammation and bronchiectasis, including frequent-exacerbator phenotypes in the EMBARC registry.
He coordinates educational programmes on bronchiectasis at Hospital Clínic and publishes widely on mucins, inhaled therapies and treatable traits in chronic airway disease.
Natalie Lorent works as a consultant in Respiratory Medicine/Clinical Infectiology at the University Hospital Leuven where since 2015 she coordinates the care for adults with respiratory infections, bronchiectasis (CF and non-CF) and primary ciliary dyskinesia. She is involved in clinical and translational research in bronchiectasis and mycobacterial infections.
She is founder and president of the national NTM Consilium, a clinical advisory board and basis of a national registry; she chairs the European NTM research network (NTMnet) and the Belgian MDRTB expert group. She has been involved in EMBARC since the start. Natalie is also assistant professor at KU Leuven.
Felix C. Ringshausen is a board-certified physician for respiratory medicine and infectious diseases and head of the Adult Bronchiectasis and Cystic Fibrosis Service at the Hannover Medical School, Germany. In addition, he is principal investigator of the German Center for Lung Research (DZL).
His research interests are focused on European multidisciplinary networks and multicenter initiatives in order to promote clinically orientated research and improve patient care in the field of rare, neglected and under-researched aspects of respiratory infections like bronchiectasis, nontuberculous mycobacteria, respiratory viruses and adult cystic fibrosis.
Professor of Respiratory Medicine, Humanitas University, Milan, Italy. Consultant, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan.
Co-chair of the European Bronchiectasis Network (EMBARC). Chair of IRIDE, the Italian Registry of adult bronchiectasis. Chair of the Italian Registry on Non-Tuberculous Mycobacteria (IRENE).
Professor Michael Loebinger is Professor of Practice at Imperial College London and Director of the Lung Division and Deputy Medical Director at Royal Brompton Hospital. He co-chaired the British Thoracic Society bronchiectasis guidelines and co-wrote the BTS Non-Tuberculous Mycobacteria and European Respiratory Society bronchiectasis guidelines.
He is a founding member of the UK and European clinical and research bronchiectasis and NTM networks and has authored over 200 publications. He has helped design and lead multiple global clinical trials in bronchiectasis and NTM and was chief investigator for the first mRNA trials in primary ciliary dyskinesia.
Charles Haworth is a Respiratory Consultant working within the Cambridge Centre for Lung Infection at Royal Papworth Hospital where he specialises in treating adults with bronchiectasis, non-tuberculous mycobacterial (NTM) infections and cystic fibrosis.
He co-authored the British Thoracic Society Bronchiectasis clinical guidelines published in 2017 and the European Respiratory Society Bronchiectasis clinical guidelines published in 2019.
He was also senior author of the International Cystic Fibrosis NTM guidelines published in 2015 and first author of the British Thoracic Society NTM guidelines published in 2017.
From 2018 to 2021, he was a founding and executive committee member of the UK Cystic Fibrosis Medical Association.
In June 2024 he was invited to join the Board of the European Cystic Fibrosis Society.
Rhodes Chair of Experimental Therapeutics and Clinical Pharmacology, University of Oxford.
Chief Editor of the European Respiratory Journal.
Chair of the European Bronchiectasis Network (EMBARC).
Chair of the Standards of Care Committee of the British Thoracic Society.
